# Artificial Intelligence (AI) Cytopathology Trial

> **NCT05018663** · — · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 50 (estimated)

## Conditions studied

- Pancreatic Solid Lesions

## Interventions

- **OTHER:** Artificial Intelligence software ROSE

## Key facts

- **NCT ID:** NCT05018663
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-21
- **Primary completion:** 2024-07-31
- **Final completion:** 2028-01-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018663, "Artificial Intelligence (AI) Cytopathology Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05018663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*